UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000009255 |
|---|---|
| Receipt number | R000010867 |
| Scientific Title | A study about measurement of glycated albumin in urine and peritoneal dialysis fluid of diabetic patientswith chronic kidney disease |
| Date of disclosure of the study information | 2015/12/31 |
| Last modified on | 2016/03/04 16:16:20 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study about measurement of glycated albumin in urine and peritoneal dialysis fluid of diabetic patientswith chronic kidney disease
Acronym
A study about measurement of glycated albumin in urine and peritoneal dialysis fluid
Scientific Title
A study about measurement of glycated albumin in urine and peritoneal dialysis fluid of diabetic patientswith chronic kidney disease
Scientific Title:Acronym
A study about measurement of glycated albumin in urine and peritoneal dialysis fluid
Region
| Japan |
Condition
Condition
Chronic kidney disease
Classification by specialty
| Nephrology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
We measure glyated oalbumin in urine and peritoneal dialysis fluid and examine influence of the glycated albumin loss.
Basic objectives2
Others
Basic objectives -Others
Measurement
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Blood glucose, glycated albumin in serum, urine and peritoneal dialysis fluid,
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Inpatients with diabetic nephropathy over 0.5 g/g Cr of proteinuria
Peritoneal dialysis patients
Key exclusion criteria
Patients who cannot collect urine during 24 hours
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kazuyoshi Okada |
Organization
Nihon University School of Medicine
Division name
Division of Nephrology, Hypertension and Endocrinology, Department of Medicine
Zip code
Address
30-1 Oyauchi-kamicho, Itabashi-ku, Tokyo, Japan
TEL
03-3972-8111
kokada@med.nihon-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | yasuko Hirukawa |
Organization
Clinical Research Institutional Review Board
Division name
Clinical Research Center
Zip code
Address
30-1 Oyauchi-kamicho, Itabashi-ku, Tokyo, Japan
TEL
03-3972-8111
Homepage URL
hirukawa.yasuko@nihon-u.ac.jp
Sponsor or person
Institute
Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 12 | Month | 31 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2012 | Year | 09 | Month | 14 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 11 | Month | 15 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We measure glycated albumin in urine and peritoneal dialysis fluid.
Management information
Registered date
| 2012 | Year | 11 | Month | 03 | Day |
Last modified on
| 2016 | Year | 03 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010867
